This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flanagan, C. A. Articles by Millar, R. P. Search for Related Content PubMed PubMed Citation Articles by Flanagan, C. A. Articles by Millar, R. P.

A High Affinity Gonadotropin-Releasing Hormone (GnRH) Tracer, Radioiodinated at Position 6, Facilitates Analysis of Mutant GnRH Receptors¹

Medical Research Council Research Unit for Molecular Reproductive Endocrinology, Department of Chemical Pathology (C.A.F., B.J.F., J.S.D., R.P.M.), and Endocrine Laboratory, Department of Medicine (C.A.F., R.P.M.), University of Cape Town Medical School, Observatory 7925, South Africa

Address all correspondence and requests for reprints to: Robert P. Millar, Director, Medical Research Council Reproductive Biology Unit, 37 Chalmers Street, Edinburgh EH, United Kingdom. E-mail: Bob{at}ed-rbu.mrc.ac.uk

Cloning of GnRH receptors from several animal species has made it possible to investigate receptor function using site-directed mutagenesis. However, many mutant GnRH receptors exhibit decreased ligand binding, which makes analysis of their ligand binding characteristics technically difficult. To increase the affinity of binding to the GnRH receptor, a novel tracer ligand, ¹²⁵I-[His⁵,D-Tyr⁶]GnRH, was designed and synthesized to allow radioiodination at position 6 rather than the usual position 5.

In competition binding assays, total binding of ¹²⁵I-[His⁵,D-Tyr⁶]GnRH was higher than binding of a conventional tracer ligand, ¹²⁵I-[D-Ala⁶,N-MeLeu⁷,Pro⁹NHEt]GnRH. The bindable fractions and specific activities of both peptides were similar, and the receptor binding affinities of the unlabeled peptides were indistinguishable. However, comparison of the radiolabeled peptides in saturation binding assays showed that the affinity of the peptide,¹²⁵I-[His⁵,D-Tyr⁶]GnRH, (K_d, 0.19 nM), was approximately 2-fold higher than that of the conventional tracer. The increased binding of ¹²⁵I-[His⁵,D-Tyr⁶]GnRH has allowed the development of a sensitive GnRH receptor binding assay for analysis of mutant GnRH receptors that exhibit decreased ligand binding.

This article has been cited by other articles:

				R. Lopez de Maturana, A. J. Pawson, Z.-L. Lu, L. Davidson, S. Maudsley, K. Morgan, S. P. Langdon, and R. P. Millar Gonadotropin-Releasing Hormone Analog Structural Determinants of Selectivity for Inhibition of Cell Growth: Support for the Concept of Ligand-Induced Selective Signaling Mol. Endocrinol., July 1, 2008; 22(7): 1711 - 1722. [Abstract] [Full Text] [PDF]

				K. D. G. Pfleger, A. J. Pawson, and R. P. Millar Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations Endocrinology, June 1, 2008; 149(6): 3118 - 3129. [Abstract] [Full Text] [PDF]

				A. J. Pawson, E. Faccenda, S. Maudsley, Z.-L. Lu, Z. Naor, and R. P. Millar Mammalian Type I Gonadotropin-Releasing Hormone Receptors Undergo Slow, Constitutive, Agonist-Independent Internalization Endocrinology, March 1, 2008; 149(3): 1415 - 1422. [Abstract] [Full Text] [PDF]

				C. A. Flanagan, C.-C. Chen, M. Coetsee, S. Mamputha, K. E. Whitlock, N. Bredenkamp, L. Grosenick, R. D. Fernald, and N. Illing Expression, Structure, Function, and Evolution of Gonadotropin-Releasing Hormone (GnRH) Receptors GnRH-R1SHS and GnRH-R2PEY in the Teleost, Astatotilapia burtoni Endocrinology, October 1, 2007; 148(10): 5060 - 5071. [Abstract] [Full Text] [PDF]

				Z. Naor, H. N. Jabbour, M. Naidich, A. J. Pawson, K. Morgan, S. Battersby, M. R. Millar, P. Brown, and R. P. Millar Reciprocal Cross Talk between Gonadotropin-Releasing Hormone (GnRH) and Prostaglandin Receptors Regulates GnRH Receptor Expression and Differential Gonadotropin Secretion Mol. Endocrinol., February 1, 2007; 21(2): 524 - 537. [Abstract] [Full Text] [PDF]

				R. S. Struthers, Q. Xie, S. K. Sullivan, G. J. Reinhart, T. A. Kohout, Y.-F. Zhu, C. Chen, X.-J. Liu, N. Ling, W. Yang, et al. Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902 Endocrinology, February 1, 2007; 148(2): 857 - 867. [Abstract] [Full Text] [PDF]

				S. Mamputha, Z.-l. Lu, R. W. Roeske, R. P. Millar, A. A. Katz, and C. A. Flanagan Conserved Amino Acid Residues that Are Important for Ligand Binding in the Type I Gonadotropin-Releasing Hormone (GnRH) Receptor Are Required for High Potency of GnRH II at the Type II GnRH Receptor Mol. Endocrinol., January 1, 2007; 21(1): 281 - 292. [Abstract] [Full Text] [PDF]

				K. Morgan, R. Sellar, A. J. Pawson, Z.-L. Lu, and R. P. Millar Bovine and Ovine Gonadotropin-Releasing Hormone (GnRH)-II Ligand Precursors and Type II GnRH Receptor Genes Are Functionally Inactivated Endocrinology, November 1, 2006; 147(11): 5041 - 5051. [Abstract] [Full Text] [PDF]

				K. E. Ratcliffe, H. M. Fraser, R. Sellar, J. Rivier, and R. P. Millar Bifunctional Gonadotropin-Releasing Hormone Antagonist-Progesterone Analogs with Increased Efficacy and Duration of Action Endocrinology, January 1, 2006; 147(1): 571 - 579. [Abstract] [Full Text] [PDF]

				Z.-L. Lu, R. Gallagher, R. Sellar, M. Coetsee, and R. P. Millar Mutations Remote from the Human Gonadotropin-releasing Hormone (GnRH) Receptor-binding Sites Specifically Increase Binding Affinity for GnRH II but Not GnRH I: EVIDENCE FOR LIGAND-SELECTIVE, RECEPTOR-ACTIVE CONFORMATIONS J. Biol. Chem., August 19, 2005; 280(33): 29796 - 29803. [Abstract] [Full Text] [PDF]

				A. J. Pawson, S. Maudsley, K. Morgan, L. Davidson, Z. Naor, and R. P. Millar Inhibition of Human Type I Gonadotropin-Releasing Hormone Receptor (GnRHR) Function by Expression of a Human Type II GnRHR Gene Fragment Endocrinology, June 1, 2005; 146(6): 2639 - 2649. [Abstract] [Full Text] [PDF]

				K. Ronacher, N. Matsiliza, N. Nkwanyana, A. J. Pawson, T. Adam, C. A. Flanagan, R. P. Millar, and A. A. Katz Serine Residues 338 and 339 in the Carboxyl-Terminal Tail of the Type II Gonadotropin-Releasing Hormone Receptor Are Critical for {beta}-Arrestin-Independent Internalization Endocrinology, October 1, 2004; 145(10): 4480 - 4488. [Abstract] [Full Text] [PDF]

				A. J. Pawson, S. R. Maudsley, J. Lopes, A. A. Katz, Y.-M. Sun, J. S. Davidson, and R. P. Millar Multiple Determinants for Rapid Agonist-Induced Internalization of a Nonmammalian Gonadotropin-Releasing Hormone Receptor: A Putative Palmitoylation Site and Threonine Doublet within the Carboxyl-Terminal Tail Are Critical Endocrinology, September 1, 2003; 144(9): 3860 - 3871. [Abstract] [Full Text] [PDF]

				K. D. G. Pfleger, J. Bogerd, and R. P. Millar Conformational Constraint of Mammalian, Chicken, and Salmon GnRHs, But Not GnRH II, Enhances Binding at Mammalian and Nonmammalian Receptors: Evidence for Preconfiguration of GnRH II Mol. Endocrinol., September 1, 2002; 16(9): 2155 - 2162. [Abstract] [Full Text] [PDF]

				B. J. Fromme, A. A. Katz, R. W. Roeske, R. P. Millar, and C. A. Flanagan Role of Aspartate7.32(302) of the Human Gonadotropin-Releasing Hormone Receptor in Stabilizing a High-Affinity Ligand Conformation Mol. Pharmacol., December 1, 2001; 60(6): 1280 - 1287. [Abstract] [Full Text] [PDF]

				R. Millar, S. Lowe, D. Conklin, A. Pawson, S. Maudsley, B. Troskie, T. Ott, M. Millar, G. Lincoln, R. Sellar, et al. A novel mammalian receptor for the evolutionarily conserved type II GnRH PNAS, August 1, 2001; (2001) 141048498. [Abstract] [Full Text] [PDF]

				R. R. Robison, R. B. White, N. Illing, B. E. Troskie, M. Morley, R. P. Millar, and R. D. Fernald Gonadotropin-Releasing Hormone Receptor in the Teleost Haplochromis burtoni: Structure, Location, and Function Endocrinology, May 1, 2001; 142(5): 1737 - 1743. [Abstract] [Full Text]

				S. H. Hoffmann, T. t. Laak, R. Kühne, H. Reiländer, and T. Beckers Residues within Transmembrane Helices 2 and 5 of the Human Gonadotropin-Releasing Hormone Receptor Contribute to Agonist and Antagonist Binding Mol. Endocrinol., July 1, 2000; 14(7): 1099 - 1115. [Abstract] [Full Text]

				B. E. Troskie, J. P. Hapgood, R. P. Millar, and N. Illing Complementary Deoxyribonucleic Acid Cloning, Gene Expression, and Ligand Selectivity of a Novel Gonadotropin-Releasing Hormone Receptor Expressed in the Pituitary and Midbrain of Xenopus laevis Endocrinology, May 1, 2000; 141(5): 1764 - 1771. [Abstract] [Full Text] [PDF]

				S. Chauvin, A. Bérault, Y. Lerrant, M. Hibert, and R. Counis Functional Importance of Transmembrane Helix 6 Trp279 and Exoloop 3 Val299 of Rat Gonadotropin-Releasing Hormone Receptor Mol. Pharmacol., March 1, 2000; 57(3): 625 - 633. [Abstract] [Full Text]

				R. Millar, S. Lowe, D. Conklin, A. Pawson, S. Maudsley, B. Troskie, T. Ott, M. Millar, G. Lincoln, R. Sellar, et al. A novel mammalian receptor for the evolutionarily conserved type II GnRH PNAS, August 14, 2001; 98(17): 9636 - 9641. [Abstract] [Full Text] [PDF]